“…A widely proposed method for overcoming this issue is the incorporation of contrast agents that can enhance optical scattering signals. Over the past few decades, although they are still in the laboratory stage of development, various materials and structures have been explored as promising contrast agents for OCT imaging, such as microbubbles, [ 13 ] carbon nanotubes, [ 14 ] magnetic nanoparticles, [ 15 ] glycerol, propylene glycol, [ 16 ] silicon nanoparticles, [ 17 ] metallic nanostructures, [ 18,19 ] fluorescent agents (e.g., indocyanine green), [ 20 ] and photosensitive proteins (e.g., phytochrome) [ 21 ] (Table S1, Supporting Information). However, most of these agents only operate in the NIR‐I window, or provide relatively small optical scattering cross‐sections in the NIR‐II window, which limits the enhancement of OCT contrast, particularly for in vivo applications.…”